Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions
Life Sciences Times
-
January 31, 2022
0
Venture Capital
Comera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.
Life Sciences Times
-
January 31, 2022
0
Venture Capital
468 Capital Raises $400 Million Fund II
Life Sciences Times
-
January 31, 2022
0
Venture Capital
causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect
Life Sciences Times
-
January 28, 2022
0
Venture Capital
BioVentrix Expands Heart Failure Treatment Portfolio with Acquisition of MateraCor, Inc.
Life Sciences Times
-
January 27, 2022
0
Venture Capital
Broad Sky Partners Announces Investment From Capital Constellation and Acquisition of Thomas Scientific
Life Sciences Times
-
January 27, 2022
0
Venture Capital
Interchecks Announces $16M Series B Financing, Co-led by Senator Investment Group and Standard Investments, to Accelerate Instant Payment Infrastructure
Life Sciences Times
-
January 27, 2022
0
Venture Capital
o9 Solutions Raises $295 Million From Strategic Investors to Continue its Growth Across Industry Verticals & Markets
Life Sciences Times
-
January 26, 2022
0
Venture Capital
SpotSee Acquires Biosynergy, Inc.
Life Sciences Times
-
January 26, 2022
0
Venture Capital
PureTech Founded Entity Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp.
Life Sciences Times
-
January 26, 2022
0
Venture Capital
​​Atlas Health Raises $40M Series A to Expand AI-Powered Patient Advocacy Solution
Life Sciences Times
-
January 25, 2022
0
Venture Capital
Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform
Life Sciences Times
-
January 25, 2022
0
1
...
86
87
88
...
115
Page 87 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026